[Determinations of clinical variations and lipid metabolism in patients with chronic ischemia of the lower extremities by means of a pentosan sulfonic ester and xanthinol niacinate combination].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007269:Injections, Intra-Arterial; D007511:Ischemia / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D007866:Leg / Q000098:blood supply*; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D010426:Pentosan Sulfuric Polyester / Q000008:administration & dosage*; D011134:Polysaccharides / Q000008:administration & dosage*; D013806:Theophylline / Q000031:analogs & derivatives*; D014971:Xanthinol Niacinate / Q000008:administration & dosage*
D008055:Lipids; D011134:Polysaccharides; D010426:Pentosan Sulfuric Polyester; D014971:Xanthinol Niacinate; D013806:Theophylline
Determinacion de la variaciones clínicas y en el metabolismo lipidi-co en pacientes con isquemia crónica de extremidades inferiores, mediante la administración de la asociación ester pentosano sulfonico-xantinol niaciato.